Former ACAAI President Michael Foggs, MD, FACAAI, was recently appointed by the Centers for Medicare and Medicaid Services (CMS) to serve a 2-year term on the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC). MEDCAC provides guidance to the Department of Health and Human Services (HHS) and CMS concerning the adequacy of scientific evidence available in making coverage determinations under the Medicare program. MEDCAC also evaluates literature and technology assessments and hears public testimony on the evidence available to address the impact of services on health outcomes of beneficiaries. MEDCAC may also advise CMS as part of Medicare's “coverage with evidence development” initiative.
MEDCAC members generally are recognized authorities in clinical medicine including subspecialties, administrative medicine, public health, biological and physical sciences, epidemiology and biostatistics, clinical trial design, health care data management and analysis, patient advocacy, health care economics, medical ethics or other relevant professions.
Dr. Foggs graduated from Yale University with a bachelor of science degree in biology and biochemistry. He earned his medical degree from Harvard Medical School and completed his internship and residency at Northwestern University Medical Center/Northwestern Memorial Hospital in Chicago. He completed fellowship in allergy and immunology at the University of Pennsylvania School of Medicine and Hospitals.
Dr. Foggs is an ACAAI Distinguished Fellow and currently serves on numerous College committees. He has served as a consultant to the National Heart, Lung & Blood Institute, the FDA, and the National Institutes of Health, and was a member of the Expert Panel 3 responsible for writing the NIH Asthma Guidelines. He is Chief of Allergy and Immunology for the Advocate Medical Group of Advocate Health Care – one of the largest integrated health care networks in the United States – in Chicago.
